Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has been given an average rating of “Buy” by the thirteen ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $27.77.

A number of equities analysts recently weighed in on the stock. JMP Securities reissued a “market outperform” rating and issued a $29.00 price target on shares of Privia Health Group in a report on Monday, April 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 28th. Barclays boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 27th. Finally, Robert W. Baird increased their target price on Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 15th.

Insider Activity at Privia Health Group

In other Privia Health Group news, Director Matthew Shawn Morris sold 10,309 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the transaction, the director directly owned 59,792 shares of the company’s stock, valued at approximately $1,394,947.36. This trade represents a 14.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Parth Mehrotra sold 15,100 shares of Privia Health Group stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $352,283.00. Following the completion of the transaction, the chief executive officer directly owned 454,281 shares in the company, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,949 shares of company stock valued at $1,100,368. Corporate insiders own 10.70% of the company’s stock.

Institutional Trading of Privia Health Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. US Bancorp DE increased its position in Privia Health Group by 2.4% during the 1st quarter. US Bancorp DE now owns 18,487 shares of the company’s stock valued at $415,000 after purchasing an additional 429 shares during the period. Quadrant Capital Group LLC grew its holdings in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the period. Park Avenue Securities LLC grew its holdings in shares of Privia Health Group by 3.6% during the 1st quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock worth $342,000 after acquiring an additional 532 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Privia Health Group by 8.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after acquiring an additional 533 shares in the last quarter. Finally, CWM LLC lifted its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after purchasing an additional 604 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $22.54 on Wednesday. The firm has a market cap of $2.75 billion, a price-to-earnings ratio of 187.85, a price-to-earnings-growth ratio of 3.68 and a beta of 0.82. The firm has a 50-day moving average price of $23.16 and a two-hundred day moving average price of $22.88. Privia Health Group has a 52 week low of $16.47 and a 52 week high of $26.09.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.